Scholarlink

Background <p>The differentiation between&#xa0;gastrointestinal tuberculosis (GITB) and Crohn’s disease (CD) is challenging. Detection of urinary&#xa0;lipoarabinomannan (LAM), a glycolipid component of the <i>Mycobacterium tuberculosis</i> cell wall, has shown potential as a non-invasive diagnostic marker for tuberculosis.</p> Objective <p>We evaluated the diagnostic accuracy of urinary LAM in distinguishing GITB from CD.</p> Methods <p>This prospective study included patients diagnosed with GITB, CD or those with indeterminate conditions (January 2021 to April 2022). Comprehensive clinical evaluations, laboratory investigations, computed tomography (CT) enterography, colonoscopy and histopathological analyses were performed. First morning midstream urine samples were collected and analyzed&#xa0;using TB LAM antigen kit. The analytical team was blinded from the clinical data. Sensitivity, specificity, positive predictive value (PPV), negative predictive value (NPV) and overall diagnostic accuracy of urinary LAM were determined.</p> Results <p>Of 98 patients, 36 were diagnosed with GITB and 62 with CD. Urinary LAM was positive in nine out of 36 GITB patients, yielding a sensitivity of 25% (95% C.I. 12.12–42.20%) and a PPV of 100% (95% C.I. 66.37–100.00%). None of the CD patients tested positive for urinary LAM, resulting in a specificity of 100% (95% C.I. 94.22–100.00%) and NPV of 69.66% (95% C.I. 65.54–73.50%). Overall diagnostic accuracy of urinary LAM in differentiating GITB from CD was 72.45% (95% C.I. 62.54–80.99%). Notably, the addition of urinary LAM testing to the existing diagnostic criteria improved the accurate identification of GITB from 44% to 55.6%.</p> Conclusion <p>Urinary LAM testing exhibits high specificity and PPV, making it a significant adjunct in the diagnostic process for GITB.</p> Graphical abstract <p></p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Urinary lipoarabinomannan: A novel diagnostic tool for distinguishing gastrointestinal tuberculosis from Crohn’s disease

  • 期刊论文

  • 发表日期：

    2025年6月19日

查看全文
  • Mukesh Singh,
  • Manjeet Kumar Goyal,
  • Himanshu Narang,
  • Malambo Mubbunu,
  • Peeyush Kumar,
  • Bhaskar Kante,
  • Sudheer K. Vuyyuru,
  • Ashish Dutt Upadhyay,
  • Prasenjit Das,
  • Ankur Goyal,
  • Raju Sharma,
  • Urvashi B. Singh,
  • Govind Makharia,
  • Saurabh Kedia,
  • Vineet Ahuja

摘要

Background

The differentiation between gastrointestinal tuberculosis (GITB) and Crohn’s disease (CD) is challenging. Detection of urinary lipoarabinomannan (LAM), a glycolipid component of the Mycobacterium tuberculosis cell wall, has shown potential as a non-invasive diagnostic marker for tuberculosis.

Objective

We evaluated the diagnostic accuracy of urinary LAM in distinguishing GITB from CD.

Methods

This prospective study included patients diagnosed with GITB, CD or those with indeterminate conditions (January 2021 to April 2022). Comprehensive clinical evaluations, laboratory investigations, computed tomography (CT) enterography, colonoscopy and histopathological analyses were performed. First morning midstream urine samples were collected and analyzed using TB LAM antigen kit. The analytical team was blinded from the clinical data. Sensitivity, specificity, positive predictive value (PPV), negative predictive value (NPV) and overall diagnostic accuracy of urinary LAM were determined.

Results

Of 98 patients, 36 were diagnosed with GITB and 62 with CD. Urinary LAM was positive in nine out of 36 GITB patients, yielding a sensitivity of 25% (95% C.I. 12.12–42.20%) and a PPV of 100% (95% C.I. 66.37–100.00%). None of the CD patients tested positive for urinary LAM, resulting in a specificity of 100% (95% C.I. 94.22–100.00%) and NPV of 69.66% (95% C.I. 65.54–73.50%). Overall diagnostic accuracy of urinary LAM in differentiating GITB from CD was 72.45% (95% C.I. 62.54–80.99%). Notably, the addition of urinary LAM testing to the existing diagnostic criteria improved the accurate identification of GITB from 44% to 55.6%.

Conclusion

Urinary LAM testing exhibits high specificity and PPV, making it a significant adjunct in the diagnostic process for GITB.

Graphical abstract